Allogene Therapeutics, Inc. short interest in 2019
In 2019, Allogene Therapeutics, Inc.'s disclosed short interest ran from 10.32% of shares outstanding on 15 Oct 2019 to 10.52% on 31 Dec 2019, a change of +0.20 percentage points. The year's high was 10.52% on 31 Dec 2019 and its low 9.60% on 13 Dec 2019, averaging 10.04% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 44.87 days on 31 Oct 2019. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 10.32% (15 Oct 2019)
- End of year
- 10.52% (31 Dec 2019)
- Change
- +0.20 pp
- High
- 10.52% (31 Dec 2019)
- Low
- 9.60% (13 Dec 2019)
- Average
- 10.04%
- Highest days to cover
- 44.87 (31 Oct 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 10.32% | 37.97 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2019 | 10.20% | 44.87 | |
| 15 Nov 2019 | 9.98% | 33.72 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 9.65% | 23.06 | |
| 13 Dec 2019 | 9.60% | 14.90 | |
| 31 Dec 2019 | 10.52% | 15.18 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.